-
1
-
-
0033926002
-
Replicative adenoviruses for cancer therapy
-
Alemany, R., Balague, C. and Curiel, D. T. (2000). Replicative adenoviruses for cancer therapy. Nat Biotechnol, 18: 723-727.
-
(2000)
Nat Biotechnol
, vol.18
, pp. 723-727
-
-
Alemany, R.1
Balague, C.2
Curiel, D.T.3
-
2
-
-
34547110354
-
The influence of blood on in vivo adenovirus bio-distribution and transduction
-
Baker, A. H., McVey, J. H., Waddington, S. N., Di Paolo, N. C. and Shayakhmetov, D. M. (2007). The influence of blood on in vivo adenovirus bio-distribution and transduction. Mol Ther, 15: 1410-1416.
-
(2007)
Mol Ther
, vol.15
, pp. 1410-1416
-
-
Baker, A.H.1
McVey, J.H.2
Waddington, S.N.3
Di Paolo, N.C.4
Shayakhmetov, D.M.5
-
3
-
-
33645980624
-
Polyethylene glycol (molecular weight 400 DA) vehicle improves gene expression of adenovirus mediated gene therapy
-
Barton, K. N., Stricker, H., Kolozsvary, A., Kohl, R., Heisey, G., Nagaraja, T. N., Zhu, G., Lu, M., Kim, J. H., Freytag, S. O. and Brown, S. L. (2006). Polyethylene glycol (molecular weight 400 DA) vehicle improves gene expression of adenovirus mediated gene therapy. J Urol, 175: 1921-1925.
-
(2006)
J Urol
, vol.175
, pp. 1921-1925
-
-
Barton, K.N.1
Stricker, H.2
Kolozsvary, A.3
Kohl, R.4
Heisey, G.5
Nagaraja, T.N.6
Zhu, G.7
Lu, M.8
Kim, J.H.9
Freytag, S.O.10
Brown, S.L.11
-
4
-
-
33645290818
-
Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor
-
Bonsted, A., Engesaeter, B. O., Hogset, A., Maelandsmo, G. M., Prasmickaite, L., D'Oliveira, C., Hennink, W. E., van Steenis, J. H. and Berg, K. (2006). Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor. J Gene Med, 8: 286-297.
-
(2006)
J Gene Med
, vol.8
, pp. 286-297
-
-
Bonsted, A.1
Engesaeter, B.O.2
Hogset, A.3
Maelandsmo, G.M.4
Prasmickaite, L.5
D'oliveira, C.6
Hennink, W.E.7
Van Steenis, J.H.8
Berg, K.9
-
5
-
-
45449114994
-
Reprogrammed viruses as cancer therapeutics: Targeted, armed and shielded
-
Cattaneo, R., Miest, T., Shashkova, E. V. and Barry, M. A. (2008). Reprogrammed viruses as cancer therapeutics: Targeted, armed and shielded. Nat Rev Microbiol, 6: 529-540.
-
(2008)
Nat Rev Microbiol
, vol.6
, pp. 529-540
-
-
Cattaneo, R.1
Miest, T.2
Shashkova, E.V.3
Barry, M.A.4
-
6
-
-
33750185394
-
Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery
-
Chan, P., Kurisawa, M., Chung, J. E. and Yang, Y. Y. (2007). Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials, 28: 540-549.
-
(2007)
Biomaterials
, vol.28
, pp. 540-549
-
-
Chan, P.1
Kurisawa, M.2
Chung, J.E.3
Yang, Y.Y.4
-
7
-
-
69549126167
-
Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells
-
Chen, L., Chen, D., Gong, M., Na, M., Li, L., Wu, H., Jiang, L., Qian, Y., Fang, G. and Xue, X. (2009). Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells. Cancer Lett, 284: 141-148.
-
(2009)
Cancer Lett
, vol.284
, pp. 141-148
-
-
Chen, L.1
Chen, D.2
Gong, M.3
Na, M.4
Li, L.5
Wu, H.6
Jiang, L.7
Qian, Y.8
Fang, G.9
Xue, X.10
-
8
-
-
0026231216
-
Adenovirus vectors for gene expression
-
Chengalvala, M. V., Lubeck, M. D., Selling, B. J., Natuk, R. J., Hsu, K. H., Mason, B. B., Chanda, P. K., Bhat, R. A., Bhat, B. M., Mizutani, S. and et al. (1991). Adenovirus vectors for gene expression. Curr Opin Biotechnol, 2: 718-722.
-
(1991)
Curr Opin Biotechnol
, vol.2
, pp. 718-722
-
-
Chengalvala, M.V.1
Lubeck, M.D.2
Selling, B.J.3
Natuk, R.J.4
Hsu, K.H.5
Mason, B.B.6
Chanda, P.K.7
Bhat, R.A.8
Bhat, B.M.9
Mizutani, S.10
-
9
-
-
76749084190
-
Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy
-
Choi, I. K., Lee, Y. S., Yoo, J. Y., Yoon, A. R., Kim, H., Kim, D. S., Seidler, D. G., Kim, J. H. and Yun, C. O. (2010). Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy. Gene Ther, 17: 190-201.
-
(2010)
Gene Ther
, vol.17
, pp. 190-201
-
-
Choi, I.K.1
Lee, Y.S.2
Yoo, J.Y.3
Yoon, A.R.4
Kim, H.5
Kim, D.S.6
Seidler, D.G.7
Kim, J.H.8
Yun, C.O.9
-
10
-
-
57749207052
-
Intravascular delivery of particulate systems: Does geometry really matter?
-
Decuzzi, P., Pasqualini, R., Arap, W. and Ferrari, M. (2009). Intravascular delivery of particulate systems: does geometry really matter? Pharm Res, 26: 235-243.
-
(2009)
Pharm Res
, vol.26
, pp. 235-243
-
-
Decuzzi, P.1
Pasqualini, R.2
Arap, W.3
Ferrari, M.4
-
11
-
-
68649104639
-
Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus
-
Doronin, K., Shashkova, E. V., May, S. M., Hofherr, S. E. and Barry, M. A. (2009). Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus. Hum Gene Ther, 20: 975-988.
-
(2009)
Hum Gene Ther
, vol.20
, pp. 975-988
-
-
Doronin, K.1
Shashkova, E.V.2
May, S.M.3
Hofherr, S.E.4
Barry, M.A.5
-
12
-
-
21144468804
-
PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability
-
Eto, Y., Gao, J. Q., Sekiguchi, F., Kurachi, S., Katayama, K., Maeda, M., Kawasaki, K., Mizuguchi, H., Hayakawa, T., Tsutsumi, Y., Mayumi, T. and Nakagawa, S. (2005). PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. J Gene Med, 7: 604-612.
-
(2005)
J Gene Med
, vol.7
, pp. 604-612
-
-
Eto, Y.1
Gao, J.Q.2
Sekiguchi, F.3
Kurachi, S.4
Katayama, K.5
Maeda, M.6
Kawasaki, K.7
Mizuguchi, H.8
Hayakawa, T.9
Tsutsumi, Y.10
Mayumi, T.11
Nakagawa, S.12
-
13
-
-
75749144753
-
HPMA copolymers for masking and retargeting of therapeutic viruses
-
Fisher, K. D. and Seymour, L. W. (2010). HPMA copolymers for masking and retargeting of therapeutic viruses. Adv Drug Deliv Rev, 62: 240-245.
-
(2010)
Adv Drug Deliv Rev
, vol.62
, pp. 240-245
-
-
Fisher, K.D.1
Seymour, L.W.2
-
14
-
-
0035077806
-
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
-
Fisher, K. D., Stallwood, Y., Green, N. K., Ulbrich, K., Mautner, V. and Seymour, L. W. (2001). Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther, 8: 341-348.
-
(2001)
Gene Ther
, vol.8
, pp. 341-348
-
-
Fisher, K.D.1
Stallwood, Y.2
Green, N.K.3
Ulbrich, K.4
Mautner, V.5
Seymour, L.W.6
-
15
-
-
34548020561
-
Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration
-
Gao, J. Q., Eto, Y., Yoshioka, Y., Sekiguchi, F., Kurachi, S., Morishige, T., Yao, X. Watanabe, H., Asavatanabodee, R., Sakurai, F., Mizuguchi, H., Okada, Y., Mukai, Y., Tsutsumi, Y., Mayumi, T., Okada, N. and Nakagawa, S. (2007). Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration. J Control Release, 122: 102-110.
-
(2007)
J Control Release
, vol.122
, pp. 102-110
-
-
Gao, J.Q.1
Eto, Y.2
Yoshioka, Y.3
Sekiguchi, F.4
Kurachi, S.5
Morishige, T.6
Yao Watanabe, X.H.7
Asavatanabodee, R.8
Sakurai, F.9
Mizuguchi, H.10
Okada, Y.11
Mukai, Y.12
Tsutsumi, Y.13
Mayumi, T.14
Okada, N.15
Nakagawa, S.16
-
16
-
-
63149110100
-
Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells
-
Gomes, E. M., Rodrigues, M. S., Phadke, A. P., Butcher, L. D., Starling, C., Chen, S., Chang, D., Hernandez-Alcoceba, R., Newman, J. T., Stone, M. J. and Tong, A. W. (2009). Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells. Clin Cancer Res, 15: 1317-1325.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 1317-1325
-
-
Gomes, E.M.1
Rodrigues, M.S.2
Phadke, A.P.3
Butcher, L.D.4
Starling, C.5
Chen, S.6
Chang, D.7
Hernandez-Alcoceba, R.8
Newman, J.T.9
Stone, M.J.10
Tong, A.W.11
-
17
-
-
4444374585
-
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus
-
Green, N. K., Herbert, C. W., Hale, S. J., Hale, A. B., Mautner, V., Harkins, R., Hermiston, T., Ulbrich, K., Fisher, K. D. and Seymour, L. W. (2004). Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus. Gene Ther, 11: 1256-1263.
-
(2004)
Gene Ther
, vol.11
, pp. 1256-1263
-
-
Green, N.K.1
Herbert, C.W.2
Hale, S.J.3
Hale, A.B.4
Mautner, V.5
Harkins, R.6
Hermiston, T.7
Ulbrich, K.8
Fisher, K.D.9
Seymour, L.W.10
-
18
-
-
40549116345
-
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer
-
Green, N. K., Morrison, J., Hale, S., Briggs, S. S., Stevenson, M., Subr, V., Ulbrich, K., Chandler, L., Mautner, V., Seymour, L. W. and Fisher, K. D. (2008). Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer. J Gene Med, 10: 280-289.
-
(2008)
J Gene Med
, vol.10
, pp. 280-289
-
-
Green, N.K.1
Morrison, J.2
Hale, S.3
Briggs, S.S.4
Stevenson, M.5
Subr, V.6
Ulbrich, K.7
Chandler, L.8
Mautner, V.9
Seymour, L.W.10
Fisher, K.D.11
-
19
-
-
84945737937
-
Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulphate synthesis in hepatocytes
-
Gressner, A. M. and Pfeiffer, T. (1986). Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulphate synthesis in hepatocytes. J Clin Chem Clin Biochem, 24: 821-829.
-
(1986)
J Clin Chem Clin Biochem
, vol.24
, pp. 821-829
-
-
Gressner, A.M.1
Pfeiffer, T.2
-
20
-
-
0033782862
-
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
-
Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson, Johannes, A.-, Williams, A., Hawkins, L. and Kirn, D. (2000). An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat Med, 6: 1134-1139.
-
(2000)
Nat Med
, vol.6
, pp. 1134-1139
-
-
Heise, C.1
Hermiston, T.2
Johnson, L.3
Brooks, G.4
Sampson Johannes, A.5
Williams, A.6
Hawkins, L.7
Kirn, D.8
-
21
-
-
34848845849
-
Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia
-
Hofherr, S. E., Mok, H., Gushiken, F. C., Lopez, J. A. and Barry, M. A. (2007). Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Hum Gene Ther, 18: 837-848.
-
(2007)
Hum Gene Ther
, vol.18
, pp. 837-848
-
-
Hofherr, S.E.1
Mok, H.2
Gushiken, F.C.3
Lopez, J.A.4
Barry, M.A.5
-
22
-
-
45749157559
-
Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression
-
Hofherr, S. E., Shashkova, E. V., Weaver, E. A., Khare, R. and Barry, M. A. (2008). Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Mol Ther, 16: 1276-1282.
-
(2008)
Mol Ther
, vol.16
, pp. 1276-1282
-
-
Hofherr, S.E.1
Shashkova, E.V.2
Weaver, E.A.3
Khare, R.4
Barry, M.A.5
-
23
-
-
0029256724
-
Biomedical and biotechnological applications of PEG- and PM-modified proteins
-
Inada, Y., Furukawa, M., Sasaki, H., Kodera, Y., Hiroto, M., Nishimura, H. and Matsushima, A. (1995). Biomedical and biotechnological applications of PEG- and PM-modified proteins. Trends Biotechnol, 13: 86-91.
-
(1995)
Trends Biotechnol
, vol.13
, pp. 86-91
-
-
Inada, Y.1
Furukawa, M.2
Sasaki, H.3
Kodera, Y.4
Hiroto, M.5
Nishimura, H.6
Matsushima, A.7
-
24
-
-
35348835660
-
Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells
-
Jung, Y., Park, H. J., Kim, P. H., Lee, J., Hyung, W., Yang, J., Ko, H., Sohn, J. H. Kim, J. H., Huh, Y. M., Yun, C. O. and Haam, S. (2007). Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells. J Control Release, 123: 164-171.
-
(2007)
J Control Release
, vol.123
, pp. 164-171
-
-
Jung, Y.1
Park, H.J.2
Kim, P.H.3
Lee, J.4
Hyung, W.5
Yang, J.6
Ko, H.7
Sohn Kim, H.J.J.H.8
Huh, Y.M.9
Yun, C.O.10
Haam, S.11
-
25
-
-
0033831080
-
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
-
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., Randlev, B., Gillenwater, A. M., Bruso, P., Kaye, S. B., Hong, W. K. and Kirn, D. H. (2000). A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med, 6: 879-885.
-
(2000)
Nat Med
, vol.6
, pp. 879-885
-
-
Khuri, F.R.1
Nemunaitis, J.2
Ganly, I.3
Arseneau, J.4
Tannock, I.F.5
Romel, L.6
Gore, M.7
Ironside, J.8
MacDougall, R.H.9
Heise, C.10
Randlev, B.11
Gillenwater, A.M.12
Bruso, P.13
Kaye, S.B.14
Hong, W.K.15
Kirn, D.H.16
-
26
-
-
33748070532
-
Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system
-
Kiang, A., Hartman, Z. C., Everett, R. S., Serra, D., Jiang, H., Frank,M. M. and Amalfitano, A. (2006). Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. Mol Ther, 14: 588-598.
-
(2006)
Mol Ther
, vol.14
, pp. 588-598
-
-
Kiang, A.1
Hartman, Z.C.2
Everett, R.S.3
Serra, D.4
Jiang, H.5
Frank, M.M.6
Amalfitano, A.7
-
27
-
-
33750207622
-
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy
-
Kim, J. H., Lee, Y. S., Kim, H., Huang, J. H., Yoon, A. R. and Yun, C. O. (2006). Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J Natl Cancer Inst, 98: 1482-1493.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 1482-1493
-
-
Kim, J.H.1
Lee, Y.S.2
Kim, H.3
Huang, J.H.4
Yoon, A.R.5
Yun, C.O.6
-
28
-
-
73249142676
-
The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy
-
[Epub 2009 Dec 3]
-
Kim, P. H., Kim, T. I., Yockman, J. W., Kim, S. W. and Yun, C. O. (2010). The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. Biomaterials, 31: 1865-1874 [Epub 2009 Dec 3].
-
(2010)
Biomaterials
, vol.31
, pp. 1865-1874
-
-
Kim, P.H.1
Kim, T.I.2
Yockman, J.W.3
Kim, S.W.4
Yun, C.O.5
-
29
-
-
34547171078
-
Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system
-
Kovacs, E. W., Hooker, J. M., Romanini, D.W., Holder, P. G., Berry, K. E. and Francis, M. B. (2007). Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. Bioconjug Chem, 18: 1140-1147.
-
(2007)
Bioconjug Chem
, vol.18
, pp. 1140-1147
-
-
Kovacs, E.W.1
Hooker, J.M.2
Romanini, D.W.3
Holder, P.G.4
Berry, K.E.5
Francis, M.B.6
-
30
-
-
37549008707
-
Modification of adenovirus gene transfer vectors with synthetic polymers: A scientific review and technical guide
-
Kreppel, F. and Kochanek, S. (2008). Modification of adenovirus gene transfer vectors with synthetic polymers: A scientific review and technical guide. Mol Ther, 16: 16-29.
-
(2008)
Mol Ther
, vol.16
, pp. 16-29
-
-
Kreppel, F.1
Kochanek, S.2
-
31
-
-
0042199037
-
Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates
-
Lanciotti, J., Song, A., Doukas, J., Sosnowski, B., Pierce, G., Gregory, R., Wadsworth, S. and O'Riordan, C. (2003). Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates. Mol Ther, 8: 99-107.
-
(2003)
Mol Ther
, vol.8
, pp. 99-107
-
-
Lanciotti, J.1
Song, A.2
Doukas, J.3
Sosnowski, B.4
Pierce, G.5
Gregory, R.6
Wadsworth, S.7
O'riordan, C.8
-
32
-
-
27844563357
-
PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization
-
Lee, G. K., Maheshri, N., Kaspar, B. and Schaffer, D. V. (2005). PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. Biotechnol Bioeng, 92: 24-34.
-
(2005)
Biotechnol Bioeng
, vol.92
, pp. 24-34
-
-
Lee, G.K.1
Maheshri, N.2
Kaspar, B.3
Schaffer, D.V.4
-
33
-
-
34247202686
-
Investigations of PEGylated recombinant adenovirus, using fluorescein-labeled polyethylene glycol
-
Lee, S., Ravindran, S. and Vellekamp, G. (2007). Investigations of PEGylated recombinant adenovirus, using fluorescein-labeled polyethylene glycol. Hum Gene Ther, 18: 286-300.
-
(2007)
Hum Gene Ther
, vol.18
, pp. 286-300
-
-
Lee, S.1
Ravindran, S.2
Vellekamp, G.3
-
34
-
-
63149150029
-
Imaging viral behavior in Mammalian cells with self-assembled capsid-quantum-dot hybrid particles
-
Li, F., Zhang, Z. P., Peng, J., Cui, Z. Q., Pang, D. W., Li, K., Wei, H. P., Zhou, Y. F., Wen, J. K. and Zhang, X. E. (2009). Imaging viral behavior in Mammalian cells with self-assembled capsid-quantum-dot hybrid particles. Small, 5: 718-726.
-
(2009)
Small
, vol.5
, pp. 718-726
-
-
Li, F.1
Zhang, Z.P.2
Peng, J.3
Cui, Z.Q.4
Pang, D.W.5
Li, K.6
Wei, H.P.7
Zhou, Y.F.8
Wen, J.K.9
Zhang, X.E.10
-
35
-
-
77954872944
-
Chemical modification of M13 bacteriophage and its application in cancer cell imaging
-
Li, K., Chen, Y., Li, S., Nguyen,H.G., Niu, Z., You, S.,Mello, C.M., Lu, X. andWang, Q. (2010). Chemical Modification of M13 Bacteriophage and Its Application in Cancer Cell Imaging. Bioconjug Chem, 21: 1369-1377.
-
(2010)
Bioconjug Chem
, vol.21
, pp. 1369-1377
-
-
Li, K.1
Chen, Y.2
Nguyen, H.G.3
Li, S.4
Niu, Z.5
You, S.6
Mello, C.M.7
Lu, X.8
Wang, Q.9
-
36
-
-
33746924877
-
Adenovirus type 5 interactions with human blood cells may compromise systemic delivery
-
Lyons, M., Onion, D., Green, N. K., Aslan, K., Rajaratnam, R., Bazan-Peregrino, M., Phipps, S., Hale, S., Mautner, V., Seymour, L. W. and Fisher, K. D. (2006). Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. Mol Ther, 14: 118-128.
-
(2006)
Mol Ther
, vol.14
, pp. 118-128
-
-
Lyons, M.1
Onion, D.2
Green, N.K.3
Aslan, K.4
Rajaratnam, R.5
Bazan-Peregrino, M.6
Phipps, S.7
Hale, S.8
Mautner, V.9
Seymour, L.W.10
Fisher, K.D.11
-
37
-
-
19944430495
-
Design and synthesis of a peptide-PEG transporter tool for carrying adenovirus vector into cells
-
Maeda, M., Kida, S., Hojo, K., Eto, Y., Gaob, J. Q., Kurachi, S., Sekiguchi, F., Mizuguchi, H., Hayakawa, T., Mayumi, T., Nakagawa, S. and Kawasaki, K. (2005). Design and synthesis of a peptide-PEG transporter tool for carrying adenovirus vector into cells. Bioorg Med Chem Lett, 15: 621-624.
-
(2005)
Bioorg Med Chem Lett
, vol.15
, pp. 621-624
-
-
Maeda, M.1
Kida, S.2
Hojo, K.3
Eto, Y.4
Gaob, J.Q.5
Kurachi, S.6
Sekiguchi, F.7
Mizuguchi, H.8
Hayakawa, T.9
Mayumi, T.10
Nakagawa, S.11
Kawasaki, K.12
-
38
-
-
10944247251
-
Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses
-
Mok, H., Palmer, D. J., Ng, P. and Barry, M. A. (2005). Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther, 11: 66-79.
-
(2005)
Mol Ther
, vol.11
, pp. 66-79
-
-
Mok, H.1
Palmer, D.J.2
Ng, P.3
Barry, M.A.4
-
39
-
-
42949138711
-
Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal
-
Mok, H., Park, J. W. and Park, T. G. (2008). Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. Bioconjug Chem, 19: 797-801.
-
(2008)
Bioconjug Chem
, vol.19
, pp. 797-801
-
-
Mok, H.1
Park, J.W.2
Park, T.G.3
-
40
-
-
38649135439
-
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor
-
Morrison, J., Briggs, S. S., Green, N., Fisher, K., Subr, V., Ulbrich, K., Kehoe, S. and Seymour, L. W. (2008). Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor. Mol Ther, 16: 244-251.
-
(2008)
Mol Ther
, vol.16
, pp. 244-251
-
-
Morrison, J.1
Briggs, S.S.2
Green, N.3
Fisher, K.4
Subr, V.5
Ulbrich, K.6
Kehoe, S.7
Seymour, L.W.8
-
41
-
-
62549159111
-
Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer
-
Morrison, J., Briggs, S. S., Green, N. K., Thoma, C., Fisher, K. D., Kehoe, S. and Seymour, L. W. (2009). Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer. Hum Gene Ther, 20: 239-251.
-
(2009)
Hum Gene Ther
, vol.20
, pp. 239-251
-
-
Morrison, J.1
Briggs, S.S.2
Green, N.K.3
Thoma, C.4
Fisher, K.D.5
Kehoe, S.6
Seymour, L.W.7
-
42
-
-
0033693231
-
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD genedeleted adenovirus, in patients with advanced head and neck cancer: A phase II trial
-
Nemunaitis, J., Ganly, I., Khuri, F., Arseneau, J., Kuhn, J., McCarty, T., Landers, S., Maples, P., Romel, L., Randlev, B., Reid, T., Kaye, S. and Kirn, D. (2000). Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD genedeleted adenovirus, in patients with advanced head and neck cancer: A phase II trial. Cancer Res, 60: 6359-6366.
-
(2000)
Cancer Res
, vol.60
, pp. 6359-6366
-
-
Nemunaitis, J.1
Ganly, I.2
Khuri, F.3
Arseneau, J.4
Kuhn, J.5
McCarty, T.6
Landers, S.7
Maples, P.8
Romel, L.9
Randlev, B.10
Reid, T.11
Kaye, S.12
Kirn, D.13
-
43
-
-
34248201700
-
In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene
-
Niu, G., Xiong, Z., Cheng, Z., Cai, W., Gambhir, S. S., Xing, L. and Chen, X. (2007). In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene. Mol Imaging Biol., 9: 126-134.
-
(2007)
Mol Imaging Biol.
, vol.9
, pp. 126-134
-
-
Niu, G.1
Xiong, Z.2
Cheng, Z.3
Cai, W.4
Gambhir, S.S.5
Xing, L.6
Chen, X.7
-
44
-
-
2442624634
-
A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo
-
Ogawara, K., Rots, M. G., Kok, R. J., Moorlag, H. E., Van Loenen, A. M., Meijer, D. K., Haisma, H. J. and Molema, G. (2004). A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum Gene Ther, 15: 433-443.
-
(2004)
Hum Gene Ther
, vol.15
, pp. 433-443
-
-
Ogawara, K.1
Rots, M.G.2
Kok, R.J.3
Moorlag, H.E.4
Van Loenen, A.M.5
Meijer, D.K.6
Haisma, H.J.7
Molema, G.8
-
45
-
-
33646907927
-
Folate immobilized and PEGylated adenovirus for retargeting to tumor cells
-
Oh, I. K., Mok, H. and Park, T. G. (2006). Folate immobilized and PEGylated adenovirus for retargeting to tumor cells. Bioconjug Chem, 17: 721-727.
-
(2006)
Bioconjug Chem
, vol.17
, pp. 721-727
-
-
Oh, I.K.1
Mok, H.2
Park, T.G.3
-
46
-
-
0033587174
-
PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vitro
-
O'Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E. and Francis, G. E. (1999). PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vitro. Hum Gene Ther, 10: 1349-1358.
-
(1999)
Hum Gene Ther
, vol.10
, pp. 1349-1358
-
-
O'riordan, C.R.1
Lachapelle, A.2
Delgado, C.3
Parkes, V.4
Wadsworth, S.C.5
Smith, A.E.6
Francis, G.E.7
-
47
-
-
37549019328
-
Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus
-
Park, J. W., Mok, H. and Park, T. G. (2008). Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus. Biochem Biophys Res Commun, 366: 769-774.
-
(2008)
Biochem Biophys Res Commun
, vol.366
, pp. 769-774
-
-
Park, J.W.1
Mok, H.2
Park, T.G.3
-
48
-
-
78149463824
-
Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy
-
2010 Jul 15. [Epub ahead of print]
-
Park, Y.,Kang, E.,Kwon, O. J.,Hwang,T., Park,H., Lee, J.M.,Kim, J.H. andYun,C.O. (2010). Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy. J Control Release, 2010 Jul 15. [Epub ahead of print].
-
(2010)
J Control Release
-
-
Park, Y.1
Kang, E.2
Kwon, O.J.3
Hwang, T.4
Park, H.5
Lee, J.M.6
Kim, J.H.7
Yun, C.O.8
-
49
-
-
33750608221
-
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
-
Parker, A. L., Waddington, S. N., Nicol, C. G., Shayakhmetov, D. M., Buckley, S. M., Denby, L., Kemball-Cook, G., Ni, S., Lieber, A., McVey, J. H., Nicklin, S. A. and Baker, A. H. (2006). Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood, 108: 2554-2561.
-
(2006)
Blood
, vol.108
, pp. 2554-2561
-
-
Parker, A.L.1
Waddington, S.N.2
Nicol, C.G.3
Shayakhmetov, D.M.4
Buckley, S.M.5
Denby, L.6
Kemball-Cook, G.7
Ni, S.8
Lieber, A.9
McVey, J.H.10
Nicklin, S.A.11
Baker, A.H.12
-
50
-
-
15444370982
-
Glycoviruses: Chemical glycosylation retargets adenoviral gene transfer
-
Pearce, O. M., Fisher, K. D., Humphries, J., Seymour, L. W., Smith, A. and Davis, B. G. (2005). Glycoviruses: Chemical glycosylation retargets adenoviral gene transfer. Angew Chem Int Ed Engl, 44: 1057-1061.
-
(2005)
Angew Chem Int Ed Engl
, vol.44
, pp. 1057-1061
-
-
Pearce, O.M.1
Fisher, K.D.2
Humphries, J.3
Seymour, L.W.4
Smith, A.5
Davis, B.G.6
-
51
-
-
39449105164
-
An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles
-
Saini, V., Martyshkin, D. V., Mirov, S. B., Perez, A., Perkins, G., Ellisman, M. H. Towner, V. D., Wu, H., Pereboeva, L., Borovjagin, A., Curiel, D. T. and Everts, M. (2008). An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles. Small, 4: 262-269.
-
(2008)
Small
, vol.4
, pp. 262-269
-
-
Saini, V.1
Martyshkin, D.V.2
Mirov, S.B.3
Perez, A.4
Perkins, G.5
Ellisman, M.H.6
Towner, V.D.7
Wu, H.8
Pereboeva, L.9
Borovjagin, A.10
Curiel, D.T.11
Everts, M.12
-
52
-
-
34347216741
-
Eradication of therapy-resistant human prostate tumors using a cancer terminator virus
-
Sarkar, D., Lebedeva, I. V., Su, Z. Z., Park, E. S., Chatman, L., Vozhilla, N., Dent, P., Curiel, D. T. and Fisher, P. B. (2007). Eradication of therapy-resistant human prostate tumors using a cancer terminator virus. Cancer Res, 67: 5434-5442.
-
(2007)
Cancer Res
, vol.67
, pp. 5434-5442
-
-
Sarkar, D.1
Lebedeva, I.V.2
Su, Z.Z.3
Park, E.S.4
Chatman, L.5
Vozhilla, N.6
Dent, P.7
Curiel, D.T.8
Fisher, P.B.9
-
53
-
-
33746265063
-
Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): Efficacious reagents for cancer gene therapy
-
Sarkar, D., Su, Z. Z. and Fisher, P. B. (2006). Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): Efficacious reagents for cancer gene therapy. Cell Cycle, 5: 1531-1536.
-
(2006)
Cell Cycle
, vol.5
, pp. 1531-1536
-
-
Sarkar, D.1
Su, Z.Z.2
Fisher, P.B.3
-
54
-
-
63649112514
-
Multifunctional cytotoxic stealth nanoparticles. A model approach with potential for cancer therapy
-
Schneider, G. F., Subr, V., Ulbrich, K. and Decher, G. (2009). Multifunctional cytotoxic stealth nanoparticles. A model approach with potential for cancer therapy. Nano Lett, 9: 636-642.
-
(2009)
Nano Lett
, vol.9
, pp. 636-642
-
-
Schneider, G.F.1
Subr, V.2
Ulbrich, K.3
Decher, G.4
-
55
-
-
59249099402
-
The cell adhesion molecule "cAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution
-
Seiradake, E., Henaff, D., Wodrich, H., Billet, O., Perreau, M., Hippert, C., Mennechet, F., Schoehn, G., Lortat-Jacob, H., Dreja, H., Ibanes, S., Kalatzis, V.,Wang, P. J., Finberg, R. W., Cusack, S. and Kremer, E. J. (2009). The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog, 5(1): e1000277.
-
(2009)
PLoS Pathog
, vol.5
, Issue.1
-
-
Seiradake, E.1
Henaff, D.2
Wodrich, H.3
Billet, O.4
Perreau, M.5
Hippert, C.6
Mennechet, F.7
Schoehn, G.8
Lortat-Jacob, H.9
Dreja, H.10
Ibanes, S.11
Kalatzis, V.12
Wang, P.J.13
Finberg, R.W.14
Cusack, S.15
Kremer, E.J.16
-
56
-
-
2342625392
-
Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors
-
Shayakhmetov, D. M., Li, Z. Y., Ni, S. and Lieber, A. (2004). Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J Virol, 78: 5368-5381.
-
(2004)
J Virol
, vol.78
, pp. 5368-5381
-
-
Shayakhmetov, D.M.1
Li, Z.Y.2
Ni, S.3
Lieber, A.4
-
57
-
-
19944430018
-
Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window
-
Shibata, H., Yoshioka, Y., Ikemizu, S., Kobayashi, K., Yamamoto, Y., Mukai, Y., Okamoto, T. Taniai, M., Kawamura, M., Abe, Y., Nakagawa, S., Hayakawa, T., Nagata, S., Yamagata, Y., Mayumi, T., Kamada, H. and Tsutsumi, Y. (2004). Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window. Clin Cancer Res, 10: 8293-8300.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 8293-8300
-
-
Shibata, H.1
Yoshioka, Y.2
Ikemizu, S.3
Kobayashi, K.4
Yamamoto, Y.5
Mukai, Y.6
Okamoto Taniai, T.M.7
Kawamura, M.8
Abe, Y.9
Nakagawa, S.10
Hayakawa, T.11
Nagata, S.12
Yamagata, Y.13
Mayumi, T.14
Kamada, H.15
Tsutsumi, Y.16
-
58
-
-
45749088958
-
Nanoengineering artificial lipid envelopes around adenovirus by self-assembly
-
Singh, R., Al, Jamal, K. T.-, Lacerda, L. and Kostarelos, K. (2008). Nanoengineering artificial lipid envelopes around adenovirus by self-assembly. ACS Nano, 2: 1040-1050.
-
(2008)
ACS Nano
, vol.2
, pp. 1040-1050
-
-
Singh, R.1
Al Jamal, K.T.2
Lacerda, L.3
Kostarelos, K.4
-
59
-
-
62549134434
-
Designer adenoviruses for nanomedicine and nanodiagnostics
-
Singh, R. and Kostarelos, K. (2009). Designer adenoviruses for nanomedicine and nanodiagnostics. Trends Biotechnol, 27: 220-229.
-
(2009)
Trends Biotechnol
, vol.27
, pp. 220-229
-
-
Singh, R.1
Kostarelos, K.2
-
60
-
-
0035125735
-
Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector
-
Steinwaerder, D. S., Carlson, C. A., Otto, D. L., Li, Z. Y., Ni, S. and Lieber, A. (2001). Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector. Nat Med, 7: 240-243.
-
(2001)
Nat Med
, vol.7
, pp. 240-243
-
-
Steinwaerder, D.S.1
Carlson, C.A.2
Otto, D.L.3
Li, Z.Y.4
Ni, S.5
Lieber, A.6
-
61
-
-
45749151118
-
Adenovirus in a synthetic membrane wrapper: An example of hybrid vigor?
-
Thompson, D. H. (2008). Adenovirus in a synthetic membrane wrapper: An example of hybrid vigor? ACS Nano, 2: 821-826.
-
(2008)
ACS Nano
, vol.2
, pp. 821-826
-
-
Thompson, D.H.1
-
62
-
-
0029786093
-
Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency
-
Tsutsumi, Y., Tsunoda, S., Kamada, H., Kihira, T., Nakagawa, S., Kaneda, Y., Kanamori, T. and Mayumi, T. (1996). Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency. Br J Cancer, 74: 1090-1095.
-
(1996)
Br J Cancer
, vol.74
, pp. 1090-1095
-
-
Tsutsumi, Y.1
Tsunoda, S.2
Kamada, H.3
Kihira, T.4
Nakagawa, S.5
Kaneda, Y.6
Kanamori, T.7
Mayumi, T.8
-
63
-
-
73849099821
-
Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis
-
Yao, X., Yoshioka, Y., Morishige, T., Eto, Y., Watanabe, H., Okada, Y., Mizuguchi, H., Mukai, Y., Okada, N. and Nakagawa, S. (2009). Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis. Gene Ther, 16: 1395-1404.
-
(2009)
Gene Ther
, vol.16
, pp. 1395-1404
-
-
Yao, X.1
Yoshioka, Y.2
Morishige, T.3
Eto, Y.4
Watanabe, H.5
Okada, Y.6
Mizuguchi, H.7
Mukai, Y.8
Okada, N.9
Nakagawa, S.10
-
64
-
-
42149120089
-
Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: Effects on antiangiogenesis and tumor growth inhibition
-
Yoo, J. Y.,Kim, J. H.,Kim, J., Huang, J. H., Zhang, S. N., Kang, Y. A.,Kim, H. and Yun, C. O. (2008). Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: Effects on antiangiogenesis and tumor growth inhibition. Gene Ther, 15: 635-651.
-
(2008)
Gene Ther
, vol.15
, pp. 635-651
-
-
Yoo, J.Y.1
Kim, J.H.2
Kim, J.3
Huang, J.H.4
Zhang, S.N.5
Kang, Y.A.6
Kim, H.7
Yun, C.O.8
-
65
-
-
33750321708
-
Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA
-
Zhang, Y. A., Nemunaitis, J., Samuel, S. K., Chen, P., Shen, Y. and Tong, A. W. (2006). Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA. Cancer Res, 66: 9736-9743.
-
(2006)
Cancer Res
, vol.66
, pp. 9736-9743
-
-
Zhang, Y.A.1
Nemunaitis, J.2
Samuel, S.K.3
Chen, P.4
Shen, Y.5
Tong, A.W.6
-
66
-
-
33749864535
-
The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer
-
Zhao, L., Dong, A., Gu, J., Liu, Z., Zhang, Y., Zhang,W.,Wang, Y., He, L., Qian, C., Qian, Q. and Liu, X. (2006). The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer. Cancer Gene Ther, 13: 1011-1022.
-
(2006)
Cancer Gene Ther
, vol.13
, pp. 1011-1022
-
-
Zhao, L.1
Dong, A.2
Gu, J.3
Liu, Z.4
Zhang, Y.5
Zhang, W.6
Wang, Y.7
He, L.8
Qian, C.9
Qian, Q.10
Liu, X.11
-
67
-
-
0036860003
-
Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles
-
Zhou,W., Yuan, X.,Wilson, A., Yang, L., Mokotoff, M., Pitt, B. and Li, S. (2002). Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles. Bioconjug Chem, 13: 1220-1225.
-
(2002)
Bioconjug Chem
, vol.13
, pp. 1220-1225
-
-
Zhou, W.1
Yuan, X.2
Wilson, A.3
Yang, L.4
Mokotoff, M.5
Pitt, B.6
Li, S.7
|